More Fast Furious guns surface at crime scenes in
More Fast & Furious guns surface at crime scenes in Mexico
POSTED AT 10:11 PM ON AUGUST 14, 2013 BY ERIKA JOHNSEN
We unfortunately haven’t had any shortage of scandalous revelations stemming from the doings of the Obama administration during the president’s tenure, but both Obama and his Department of Justice have pretty much succeeded in sweeping under the rug the deadly and ongoing consequences of one of their shadiest undertakings yet.
The media was all too happy to move on after Attorney General was formally held in contempt of Congress last year for failing to turn over subpoenaed documents relating to Operation Fast & Furious, the administration’s not -”botched” exercise in walking guns to Mexican drug cartels, and no, in case you were wondering — the Obama administration still hasn’t complied with Congressional requests for more information. They’d really be happy to just forget the whole thing ever happened, you see — but in the latest update from CBS News , Sharyl Atkisson reports that three more Fast & Furious weapons have turned up at crime scenes in Mexico, meaning that the results of what we could most charitably call the Obama administration’s outrageous negligence are far from finished.
According to Justice Department tracing documents obtained by CBS News , all three guns are WASR-10 762-caliber Romanian rifles. Two were purchased by Fast and Furious suspect Uriel Patino in May and July of 2010. Sean Steward, who was convicted on gun charges in July 2012, purchased a third. The rifles were traced yesterday to the Lone Wolf gun shop in Glendale, Ariz.
During Fast and Furious and similar operations, federal agents from the Bureau of Alcohol, Tobacco and Firearms (ATF) encouraged the Lone Wolf and other gun stores to sell massive amounts of weapons to questionable purchasers who allegedly trafficked them Mexican drug cartels.
Patino is said to have purchased 700 guns while under ATF’s watch . Ever since, a steady stream of the guns have been recovered at crime scenes in Mexico and the U.S. But the Justice Department has refused repeated requests from Congress and CBS News to provide a full accounting. An estimated 1,400 guns are still on the street or unaccounted for.
This isn’t the first instance of the Operation’s still-developing and bloody fallout even just this summer, and while Republicans in Congress are trying to hold the DOJ’s feet to the fire on publicly acknowledging the related crimes, the actually ‘obstructionist’ Obama administration isn’t going to do much of anything they don’t want to do. For them, limits on executive privilege are more like guidelines than actual rules.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...
Continue Reading
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
"blog__more">
More News Articles
